Tumor microenvironment in pancreatic ductal adenocarcinoma: Implications in immunotherapy

Pancreatic ductal adenocarcinoma is one of the most aggressive and lethal cancers. Surgical resection is the only curable treatment option, but it is available for only a small fraction of patients at the time of diagnosis. With current therapeutic regimens, the average 5-year survival rate is less...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Caitlyn, Zheng, Wei, Dong, Jixin, Wang, Yaohong, Lai, Jinping, Liu, Xiuli, Yin, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346457/
https://www.ncbi.nlm.nih.gov/pubmed/36158269
http://dx.doi.org/10.3748/wjg.v28.i27.3297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346457/
https://www.ncbi.nlm.nih.gov/pubmed/36158269
http://dx.doi.org/10.3748/wjg.v28.i27.3297

Ejemplares similares